Ticarcillin

DB01607ApprovedVet approvedWithdrawnSmall moleculePenicillins

Ticarcillin is a beta lactam antibiotic used to treat a variety of infections in the body. An antibiotic derived from penicillin similar to carbenicillin in action.

Mechanism: Ticarcillin's principal mechanism of action revolves around its capacity to prevent the cross-linking of peptidoglycan during bacterial cell wall synthesis. Consequently, when the offending bacteria attempt to undergo cell division, cell death occurs.
Curator reviewed
Primary indication: For the treatment of bacterial infections.Curator reviewed · 1 structured indication
Formula / weight: C₁₅H₁₆N₂O₆S₂ · 384.427 g/mol (avg)
First approval: Canada, 2001 · United States, 1990

Resolves to

Compound

UNIIF93UJX4SWTCAS34787-01-4ChEMBLCHEMBL1449ChEBI9587PubChem36921KEGGC07139

Clinical / RWD

RxNorm10591ATCJ01CA13ATCJ01CR50PharmGKBPA451684

Structure

InChIKeyOHKOGUYZJXTSFX-KZFFXBSXSA-NSMILES[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](C(O)=O)C1=CSC=C1)C(O)=O

Targets

C1KC03mecA

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

192Drug interactionsStructured to mechanism, not free text

9Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

8Marketed productsAcross 2 countries and 2 labellers

2ATC codesIncluding every combination product, plus 12 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ticarcillin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In